Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.3K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.3K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

888
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
888

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

M-Sec promotes the production of infectious HIV-1 virus through the exocyst complex in macrophages.

PLoS pathogens·2026
Same author

Author Correction: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.

Nature·2026
Same author

Virological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia.

Cell·2026
Same author

Human peritoneal CCR2<sup>Low</sup>CRIg<sup>High</sup> macrophage subset exhibits embryonic origin-like phenotypes.

Human cell·2026
Same author

The Differentially Regulated Cousins: Insights into the Differences in Transcriptional Regulatory Mechanisms Between HTLV-1 and HIV-1.

Viruses·2026
Same author

A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity.

Nature communications·2025

Related Experiment Video

Updated: Aug 28, 2025

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

14.2K

Inhibitory and Stimulatory Effects of IL-32 on HIV-1 Infection.

Hesham Nasser1, Naofumi Takahashi1, Youssef M Eltalkhawy1

  • 1Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan; and.

Journal of Immunology (Baltimore, Md. : 1950)
|September 21, 2022
PubMed
Summary

Interleukin-32 (IL-32) inhibits HIV-1 in macrophages by activating SAMHD1 but also promotes viral spread by upregulating immunosuppressive molecules and cell motility.

More Related Videos

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

17.5K
New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

11.3K

Related Experiment Videos

Last Updated: Aug 28, 2025

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

14.2K
Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

17.5K
New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

11.3K

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • The role of the proinflammatory cytokine IL-32 in HIV-1 infection is complex, as it differentially affects viral production in various cell types.
  • IL-32 is elevated in HIV-1-infected individuals, but its precise impact on viral dynamics and host response requires elucidation.

Purpose of the Study:

  • To investigate the mechanisms underlying IL-32's dual role in HIV-1 replication within human monocyte-derived macrophages (MDMs) and CD4+ T cells.
  • To determine the contribution of SAMHD1 and other immunosuppressive molecules to IL-32's effects on HIV-1.

Main Methods:

  • Assessing IL-32's impact on HIV-1 production in MDMs and CD4+ T cells.
  • Investigating the role of SAMHD1 by depleting it and examining its activation state.
  • Analyzing the expression of immunosuppressive molecules like IDO1 and PD-L1.
  • Evaluating the effect of IL-32 on MDM motility.

Main Results:

  • IL-32's inhibitory effect on HIV-1 in MDMs is dependent on SAMHD1, a dNTP triphosphohydrolase, by increasing its active unphosphorylated form.
  • IL-32 upregulates immunosuppressive molecules (IDO1, PD-L1) and enhances MDM motility, potentially facilitating HIV-1 transmission.
  • The anti-HIV-1 activity of IL-32 is confined to noncycling MDMs due to SAMHD1, unlike cycling CD4+ T cells.

Conclusions:

  • IL-32 exhibits both direct antiviral activity in MDMs via SAMHD1 and indirect pro-viral effects through immune modulation.
  • The stimulatory effects of IL-32 on HIV-1 infection, such as promoting cell motility and immunosuppression, may outweigh its direct inhibitory effects.
  • Understanding IL-32's complex role is crucial for developing effective HIV-1 therapeutic strategies.